Biomarkers – Products

AMSBIO reports that its extensive range of FDA tissue microarrays reliably enhances tissue cross-reactivity (TCR) and other target validation studies.

Collaboration aims to grow clinical evidence supporting the use of bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types.

Revolutionary genomic research applied an innovative use of multiomics and biomimetic digital twins to unveil new DNA variants associated with the development of endometrial related disorders.

Highly sensitive and multiplexed assay for the detection, discrimination, and quantification of key mutations in ESR1 gene for breast cancer, developed for bio-Rad’s QX600™ droplet digital™ PCR system.

Instrument Breaks the Boundaries of EV Detection, Providing Access to New Data Points.

Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands), proudly announces changing its name to Cerba Research as of the 1st of April 2024.

InSphero's Liver Disease team has published a groundbreaking peer-reviewed paper in Nature's Scientific Reports, challenging the limitations of in vitro models in MASH Drug Discovery.

Ella is a benchtop automated ELISA platform designed to deliver accurate, reproducible data with no manual steps.

Aptamer Group plc announces the second phase of its on-going partnership with Neuro-Bio to develop Optimer binders for a lateral flow test for the early diagnosis of Alzheimer’s disease.

New methods enable deep coverage of the blood and tissue proteome, expand capabilities for dynamic biomarker discovery to include metabolites, lipids, and proteins.